Using multimedia health education to reduce anxiety in patients with vitreous floaters
Effectiveness of Multimedia Health Education to Reduce Anxiety in Patients With Vitreous Floaters
NA · Changzhou No.2 People's Hospital · NCT06964867
This study tests if using multimedia health education can help reduce anxiety in patients dealing with vitreous floaters compared to traditional education methods.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 300 (estimated) |
| Sex | All |
| Sponsor | Changzhou No.2 People's Hospital (other) |
| Locations | 1 site (Changzhou, Jiangsu) |
| Trial ID | NCT06964867 on ClinicalTrials.gov |
What this trial studies
This clinical trial investigates the effectiveness of multimedia health education in reducing anxiety among patients suffering from vitreous floaters. Participants are randomly assigned to either a control group receiving conventional oral education or an experimental group engaging in multimedia health education activities. The study evaluates the impact of these educational interventions on patients' anxiety levels and visual function through validated questionnaires before and after the intervention. The trial is conducted at the Second People's Hospital of Changzhou, focusing on patients diagnosed with endogenous vitreous floaters.
Who should consider this trial
Good fit: Ideal candidates for this study are patients diagnosed with endogenous vitreous floaters who are willing to participate in the multimedia health education program.
Not a fit: Patients with secondary vitreous floaters requiring surgical intervention or those with coexisting ocular pathologies may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly reduce anxiety levels in patients with vitreous floaters, improving their overall quality of life.
How similar studies have performed: While multimedia health education is a relatively novel approach in this context, similar studies have shown promise in reducing anxiety in other medical conditions.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Clinical diagnosis of vitreous floaters; 2. Be able to complete questionnaires. Exclusion Criteria: 1. Secondary VF requiring surgical intervention; 2. Coexisting ocular pathologies potentially confounding vitreoretinal anatomy; 3. History of vitreoretinal surgery.
Where this trial is running
Changzhou, Jiangsu
- the Second People's Hospital of Changzhou — Changzhou, Jiangsu, China (RECRUITING)
Study contacts
- Study coordinator: Qing Feng
- Email: fengqing20001128@163.com
- Phone: 15098912007
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Vitreous Floaters, Anxiety, vitreous floaters, anxiety, health education, STAI, VFQ-25